Navigating Vaccine Safety Concerns: AstraZeneca's Admission and India's Response

Amidst the turmoil of the COVID-19 pandemic, the question of whom to trust becomes paramount. With lives lost and livelihoods shattered, the spotlight falls on the companies behind the vaccines. However, recent claims have surfaced regarding potential health issues associated with vaccination. As we navigate these uncertain times, transparency and accountability from all parties involved are crucial. Let's ensure that decisions regarding our health and safety are based on reliable information and genuine concern for the well-being of all. In recent studies, The British pharmaceutical company AstraZeneca has admitted in court documents that its vaccine against Covid-19 has the potential to cause TTS, a rare side effect associated with blood clotting. This news has affected millions worldwide, including people in India, where the vaccine, under the brand name of Covishield, was administered to reduce severe Covid-19 complications. On the other hand, many doctors have admitted that in India, the incidence of TTS after the vaccine is not known.